Hannah Valantine Bridge Bio Pharma, Inc. (BBIO) insider trading activity
Hannah Valantine is of BridgeBio Pharma, Inc.. Currently has a direct ownership of 1,764 shares of BBIO, which is worth approximately $44,946. The most recent transaction as insider was on Feb 15, 2024, when has been sold 2,915 shares (Common Stock) at a price of $37.75 per share, resulting in proceeds of $110,041. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.76K
0%
3M change
0%
12M change
Total Value Held
$44,946
Hannah Valantine Transaction History
Also insider at
HV
Hannah Valantine
South San Francisco, CA